PRNewsWire
30 Dec 2025, 14:30 UTC · 44w ago
INSP SHAREHOLDER NOTICE: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
Impact · against what's priced in
Inspire Medical Systems faces a severe valuation hit following an 80% cut to 2025 EPS guidance and a subsequent securities fraud lawsuit. The stock's decline reflects a failed Inspire V launch driven by Medicare billing delays, inventory gluts of older devices, and provider onboarding failures.
- INSP−0.90
No priced-in read yet





